These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32699110)

  • 1. Quantitative propagation of assembled human Tau from Alzheimer's disease brain in microfluidic neuronal cultures.
    Katsikoudi A; Ficulle E; Cavallini A; Sharman G; Guyot A; Zagnoni M; Eastwood BJ; Hutton M; Bose S
    J Biol Chem; 2020 Sep; 295(37):13079-13093. PubMed ID: 32699110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
    Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
    Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease-like pathology-triggered oxidative stress, alterations in monoamines levels, and structural damage of locus coeruleus neurons are partially recovered by a mix of proteoglycans of embryonic genesis.
    Aghajanov M; Chavushyan V; Matinyan S; Danielyan M; Yenkoyan K
    Neurochem Int; 2019 Dec; 131():104531. PubMed ID: 31425747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain.
    Takeda S; Wegmann S; Cho H; DeVos SL; Commins C; Roe AD; Nicholls SB; Carlson GA; Pitstick R; Nobuhara CK; Costantino I; Frosch MP; Müller DJ; Irimia D; Hyman BT
    Nat Commun; 2015 Oct; 6():8490. PubMed ID: 26458742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimalistic in vitro systems for investigating tau pathology.
    Hallinan GI; Pitera AP; Patel P; West J; Deinhardt K
    J Neurosci Methods; 2019 May; 319():69-76. PubMed ID: 30278185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An experimental model of Braak's pretangle proposal for the origin of Alzheimer's disease: the role of locus coeruleus in early symptom development.
    Ghosh A; Torraville SE; Mukherjee B; Walling SG; Martin GM; Harley CW; Yuan Q
    Alzheimers Res Ther; 2019 Jul; 11(1):59. PubMed ID: 31266535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections.
    Iba M; McBride JD; Guo JL; Zhang B; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2015 Sep; 130(3):349-62. PubMed ID: 26150341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Populations of Human Locus Ceruleus Neurons Contain Heavy Metals or Hyperphosphorylated Tau: Implications for Amyloid-β and Tau Pathology in Alzheimer's Disease.
    Pamphlett R; Kum Jew S
    J Alzheimers Dis; 2015; 45(2):437-47. PubMed ID: 25547633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex.
    Welikovitch LA; Do Carmo S; Maglóczky Z; Szocsics P; Lőke J; Freund T; Cuello AC
    Acta Neuropathol; 2018 Dec; 136(6):901-917. PubMed ID: 30362029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity.
    Wegmann S; Maury EA; Kirk MJ; Saqran L; Roe A; DeVos SL; Nicholls S; Fan Z; Takeda S; Cagsal-Getkin O; William CM; Spires-Jones TL; Pitstick R; Carlson GA; Pooler AM; Hyman BT
    EMBO J; 2015 Dec; 34(24):3028-41. PubMed ID: 26538322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.
    Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT
    J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The release and trans-synaptic transmission of Tau via exosomes.
    Wang Y; Balaji V; Kaniyappan S; Krüger L; Irsen S; Tepper K; Chandupatla R; Maetzler W; Schneider A; Mandelkow E; Mandelkow EM
    Mol Neurodegener; 2017 Jan; 12(1):5. PubMed ID: 28086931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
    Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
    J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of microglia and inhibition of exosome synthesis halt tau propagation.
    Asai H; Ikezu S; Tsunoda S; Medalla M; Luebke J; Haydar T; Wolozin B; Butovsky O; Kügler S; Ikezu T
    Nat Neurosci; 2015 Nov; 18(11):1584-93. PubMed ID: 26436904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
    Shibuya Y; Niu Z; Bryleva EY; Harris BT; Murphy SR; Kheirollah A; Bowen ZD; Chang CCY; Chang TY
    Neurobiol Aging; 2015 Jul; 36(7):2248-2259. PubMed ID: 25930235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus.
    Kang SS; Liu X; Ahn EH; Xiang J; Manfredsson FP; Yang X; Luo HR; Liles LC; Weinshenker D; Ye K
    J Clin Invest; 2020 Jan; 130(1):422-437. PubMed ID: 31793911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-pathological connected primary neurons in a microfluidic device for Alzheimer studies.
    Kunze A; Meissner R; Brando S; Renaud P
    Biotechnol Bioeng; 2011 Sep; 108(9):2241-5. PubMed ID: 21391208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.